The Nation - News from Sept. 9, 1986
A public health advocacy group asked the Food and Drug Administration to order warning labels for a popular arthritis remedy, saying that the drug can be dangerous. The Public Citizen Health Research Group said clinical studies in Canada have shown that elderly patients taking Feldene attain a higher level of the drug in their blood than younger patients on the same dosage, and that this can cause gastrointestinal bleeding.
More to Read
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
